Mark R. Wicker

During his many years of practice, Mark has built a reputation for developing sophisticated business models and formulating business-centric legal solutions to the complex challenges biotechnology and life sciences companies face as they bring novel therapeutics and diagnostics to market. He also works in tandem with colleagues in the area of intellectual property and patent litigation to develop adversarial licensing programs and to negotiate settlement and key licensing agreements. Additionally, Mark has significant corporate experience in areas such as venture capital financing, public securities offerings, and mergers and acquisitions.

Mark regularly speaks and offers commentary on life sciences and technology issues, including startup capital raising and formation and licensing transactions.